Global
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 669.91 B |
Jan. 14, 2025 | USD 744.91 | -6.59% |
|
United States |
|
2 |
USD 500.40 B |
Jan. 14, 2025 | USD 543.74 | 0.48% |
|
United States |
|
3 |
USD 362.18 B |
Jan. 14, 2025 | USD 81.56 | -2.90% |
|
Denmark |
|
4 |
USD 348.50 B |
Jan. 14, 2025 | USD 144.75 | 0.19% |
|
United States |
|
5 |
USD 310.22 B |
Jan. 14, 2025 | USD 175.55 | -0.67% |
|
United States |
|
6 |
USD 252.08 B |
Jan. 14, 2025 | USD 99.65 | -1.32% |
|
United States |
|
7 |
USD 233.77 B |
Jan. 14, 2025 | USD 310.22 | 0.71% |
|
Switzerland |
|
8 |
USD 213.05 B |
Jan. 14, 2025 | USD 556.99 | 0.27% |
|
United States |
|
9 |
USD 201.21 B |
Jan. 14, 2025 | USD 129.77 | -1.69% |
|
United Kingdom |
|
10 |
USD 197.34 B |
Jan. 14, 2025 | USD 98.71 | -0.26% |
|
Switzerland |
|
11 |
USD 196.03 B |
Jan. 14, 2025 | USD 113.02 | -0.15% |
|
United States |
|
12 |
USD 191.94 B |
Jan. 14, 2025 | USD 538.88 | -0.16% |
|
United States |
|
13 |
USD 171.63 B |
Jan. 14, 2025 | USD 237.62 | -0.94% |
|
United States |
|
14 |
USD 149.67 B |
Jan. 14, 2025 | USD 26.41 | -1.46% |
|
United States |
|
15 |
USD 143.58 B |
Jan. 14, 2025 | USD 267.10 | -1.14% |
|
United States |
|
16 |
USD 140.97 B |
Jan. 14, 2025 | USD 95.65 | 1.10% |
|
United States |
|
17 |
USD 121.27 B |
Jan. 14, 2025 | USD 96.09 | -1.23% |
|
France |
|
18 |
USD 113.41 B |
Jan. 14, 2025 | USD 91.00 | 1.18% |
|
United States |
|
19 |
USD 113.05 B |
Jan. 14, 2025 | USD 55.74 | 0.69% |
|
United States |
|
20 |
USD 109.32 B |
Jan. 14, 2025 | USD 85.25 | 4.23% |
|
Ireland |
|
21 |
USD 106.01 B |
Jan. 14, 2025 | USD 411.66 | -0.41% |
|
United States |
|
22 |
USD 85.21 B |
Jan. 14, 2025 | USD 45.94 | 0.03% |
|
United Kingdom |
|
23 |
USD 82.78 B |
Jan. 14, 2025 | USD 173.13 | 0.11% |
|
Australia |
|
24 |
USD 79.28 B |
Jan. 14, 2025 | USD 285.03 | 0.91% |
|
United States |
|
25 |
USD 75.92 B |
Jan. 14, 2025 | USD 690.87 | -3.63% |
|
United States |
|
26 |
USD 75.37 B |
Jan. 14, 2025 | USD 593.73 | 1.48% |
|
United States |
|
27 |
USD 74.18 B |
Jan. 14, 2025 | USD 164.41 | -1.15% |
|
United States |
|
28 |
USD 71.63 B |
Jan. 14, 2025 | USD 87.67 | 0.65% |
|
United States |
|
29 |
USD 69.62 B |
Jan. 14, 2025 | USD 43.03 | 0.75% |
|
Japan |
|
30 |
USD 68.38 B |
Jan. 14, 2025 | USD 235.80 | -0.17% |
|
United States |
|
31 |
USD 64.90 B |
Jan. 14, 2025 | USD 51.57 | 0.10% |
|
United States |
|
32 |
USD 64.43 B |
Jan. 14, 2025 | USD 15.79 | -2.73% |
|
United Kingdom |
|
33 |
USD 63.11 B |
Jan. 14, 2025 | USD 145.16 | 0.75% |
|
Germany |
|
34 |
USD 60.41 B |
Jan. 14, 2025 | USD 52.62 | 1.24% |
|
Germany |
|
35 |
USD 49.80 B |
Jan. 14, 2025 | USD 698.37 | 1.93% |
|
South Korea |
|
36 |
USD 48.75 B |
Jan. 14, 2025 | USD 26.30 | 0.47% |
|
Japan |
|
37 |
USD 48.57 B |
Jan. 14, 2025 | USD 20.46 | 1.52% |
|
India |
|
38 |
USD 46.40 B |
Jan. 14, 2025 | USD 240.05 | 1.68% |
|
United States |
|
39 |
USD 44.62 B |
Jan. 14, 2025 | USD 128.19 | -0.84% |
|
Japan |
|
40 |
USD 44.28 B |
Jan. 14, 2025 | USD 24.69 | -1.27% |
|
Japan |
|
41 |
USD 42.45 B |
Jan. 14, 2025 | USD 588.68 | -0.80% |
|
Switzerland |
|
42 |
USD 41.90 B |
Jan. 14, 2025 | USD 71.04 | -0.07% |
|
United States |
|
43 |
USD 41.18 B |
Jan. 14, 2025 | USD 26.08 | -0.18% |
|
Japan |
|
44 |
USD 41.01 B |
Jan. 14, 2025 | USD 82.92 | 0.05% |
|
Switzerland |
|
45 |
USD 40.96 B |
Jan. 14, 2025 | USD 143.43 | 1.04% |
|
United States |
|
46 |
USD 40.74 B |
Jan. 14, 2025 | USD 59.37 | -0.51% |
|
United Kingdom |
|
47 |
USD 40.53 B |
Jan. 14, 2025 | USD 4.48 | -0.21% |
|
United Kingdom |
|
48 |
USD 40.28 B |
Jan. 14, 2025 | USD 673.61 | 1.66% |
|
Netherlands |
|
49 |
USD 38.89 B |
Jan. 14, 2025 | USD 32.18 | 1.97% |
|
China |
|
50 |
USD 38.60 B |
Jan. 14, 2025 | USD 42.18 | 0.76% |
|
Ireland |
The Pharmaceuticals company with the highest Market Capitalization is Eli Lilly and Company (NYSE: LLY) at USD 669.91 B.
The Pharmaceuticals company with the lowest Market Capitalization is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at USD 95.91 K.
The top 10 Pharmaceuticals companies the Global by Market Capitalization are Eli Lilly and Company, UnitedHealth Group Incorporated, Novo Nordisk A/S, Johnson & Johnson, AbbVie Inc., Merck & Co., Inc., Roche Holding AG, Thermo Fisher Scientific Inc., AstraZeneca PLC and Novartis AG.
The bottom 10 Pharmaceuticals companies by Market Capitalization are Neovacs S.A., Ellen AB (publ), Beeio Honey Ltd, Qlife Holding AB (publ), Aptahem AB (publ), Nextgen Biomed Ltd, Chordate Medical Holding AB (publ), Ovoca Bio plc, M.W. Trade SA and Qlucore Ab (Publ).